Literature DB >> 10821726

Immunoglobulin levels in bronchoalveolar lavage fluid of children with chronic chest disease.

R Kitz1, P Ahrens, S Zielen.   

Abstract

The concentration and distribution of immunoglobulin isotypes (IgG, IgM, sIgA) and IgG-subclass levels (IgG-1-4) were measured in bronchoalveolar lavage fluid (BALF) in 47 children with chronic chest disease (age range 1.0-9.9 years) and 18 healthy controls (age range 1.0-6.25 years). Of these patients, 19 had nonallergic asthma (Group A), 19 suffered from recurrent pneumonia or chronic bronchitis (Group B), and 9 patients had IgG-2 deficiency (Group C). In all individuals, IgG was the predominant immunoglobulin in the lower respiratory tract, followed by IgA and IgM. In patients of Group A and B, IgG, IgM and IgA levels in BALF were significantly elevated when compared to controls. Assessment of IgG-subclass concentrations in BALF revealed that IgG-1 levels were increased in Group A and B when compared to controls (P < 0.05). Since this difference could not be explained by difference in age, it is possibly due to the inflammatory process at the mucosal level. IgG-2 levels were elevated in all patients except those with IgG-2 deficiency. IgG-2 concentration in the IgG-2 deficent group was lower compared to controls (P < 0.005) and patients in Group A (P < 0.0005) and B (P < 0.005). IgG-3 levels were elevated in asthmatics in group A compared to healthy controls (P < 0.005). IgG-4 concentrations were the same in all study groups. Since IgG-subclasses in percentage of total IgG were similar in BALF and serum, our results do not indicate a local production of any of the IgG-subclasses in the respiratory tract. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821726     DOI: 10.1002/(sici)1099-0496(200006)29:6<443::aid-ppul6>3.0.co;2-m

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  8 in total

1.  Expression and transport functionality of FcRn within rat alveolar epithelium: a study in primary cell culture and in the isolated perfused lung.

Authors:  Masahiro Sakagami; Yadollah Omidi; Lee Campbell; Lana E Kandalaft; Christopher J Morris; Jaleh Barar; Mark Gumbleton
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

2.  Alveolar and serum antiphospholipid antibodies in acute respiratory distress syndrome associated with catastrophic antiphospholipid syndrome.

Authors:  F J Wiedermann
Journal:  Ann Rheum Dis       Date:  2006-03       Impact factor: 19.103

3.  IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling.

Authors:  Melissa Y Tjota; Jesse W Williams; Tiffany Lu; Bryan S Clay; Tiara Byrd; Cara L Hrusch; Donna C Decker; Claudia Alves de Araujo; Paul J Bryce; Anne I Sperling
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

Review 4.  Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based Therapeutics.

Authors:  Kine Marita Knudsen Sand; Malin Bern; Jeannette Nilsen; Hanna Theodora Noordzij; Inger Sandlie; Jan Terje Andersen
Journal:  Front Immunol       Date:  2015-01-26       Impact factor: 7.561

Review 5.  Polyvalent Immunoglobulin as a Potential Treatment Option for Patients with Recurrent COPD Exacerbations.

Authors:  Dana Unninayar; Sara J Abdallah; D William Cameron; Juthaporn Cowan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-03-02

6.  The contribution of allergen-specific IgG to the development of th2-mediated airway inflammation.

Authors:  Jesse W Williams; Melissa Y Tjota; Anne I Sperling
Journal:  J Allergy (Cairo)       Date:  2012-10-21

7.  Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung.

Authors:  Gerburg M Spiekermann; Patricia W Finn; E Sally Ward; Jennifer Dumont; Bonny L Dickinson; Richard S Blumberg; Wayne I Lencer
Journal:  J Exp Med       Date:  2002-08-05       Impact factor: 14.307

8.  Immunoglobulin levels, cytology and microbiologic investigations of broncho-alveolar lavage in children with cystic fibrosis.

Authors:  Guergana Petrova; Tanya Strateva; Nikolay Ulevinov; Penka Perenovska
Journal:  Braz J Infect Dis       Date:  2013-02-27       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.